{"product_id":"r-e-t-a-t-r-u-t-i-d-e-40mg","title":"R E T A T R U T I D E 40mg","description":"\u003cp\u003e\u003cspan\u003eRetatrutide is an investigational “triple-agonist” peptide being studied for weight loss and metabolic health. It works by activating three hormone receptors involved in appetite, blood sugar, and energy balance:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eGLP-1\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eGIP\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eGlucagon\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eThat’s why people often call it a “multi-agonist” or “triple-agonist” peptide.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eHow it works\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eRetatrutide is designed to:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eReduce appetite and cravings\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eSlow stomach emptying so you stay full longer\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eHelp regulate blood sugar\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003ePotentially increase calorie burning\/fat metabolism through glucagon activity\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003ePotential benefits seen in studies\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eResearch trials have shown promising results for:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eSignificant weight loss\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eReduced hunger\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eBetter blood sugar control\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eImproved insulin sensitivity\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eReduction in waist circumference\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003ePossible improvements in fatty liver markers and cardiometabolic health\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eSome clinical trials showed participants losing very large percentages of body weight over time when combined with diet and lifestyle changes.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eWhy people say it’s different\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eMost older GLP-1 medications target only one pathway. Retatrutide targets three pathways, which may:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eImprove fullness\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eHelp with energy expenditure\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003ePotentially lead to greater overall weight reduction\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eCommon side effects reported\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eLike many GLP-1 related medications, the most common side effects in studies included:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eNausea\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eVomiting\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eDiarrhea\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eConstipation\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eStomach pain\/bloating\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eFatigue\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eThese are usually more noticeable during dose increases.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eRetatrutide is a triple agonist peptide targeting the glucose-dependent insulinotropic polypeptide receptor (GIPR), glucagon-like peptide-1 receptor (GLP-1R), and glucagon receptor (GCGR), with a molecular weight of approximately 4,605.2 Da. This synthetic peptide represents the first triple incretin\/glucagon receptor agonist to advance significantly in preclinical and clinical investigation. The compound incorporates structural elements from GIP, GLP-1, and glucagon sequences, with modifications including DPP-IV-resistant substitutions and a C20 fatty diacid acylation moiety for albumin binding and extended stability in serum-containing experimental systems.\u003c\/p\u003e\n\u003cp\u003eThe triple receptor agonism of retatrutide distinguishes it from dual agonists such as tirzepatide. In GCGR-expressing hepatocyte models, retatrutide activates glucagon receptor signaling through Gs-coupled cAMP elevation, stimulating glycogenolysis and gluconeogenic gene expression (PEPCK, G6Pase). In GLP-1R-expressing cell lines, concentration-dependent cAMP accumulation has been characterized, with signaling profiles comparable to established GLP-1R agonists. GIPR activation has been confirmed in receptor-transfected cell models using cAMP reporter assays and β-arrestin recruitment studies.\u003c\/p\u003e\n\u003cp\u003eThe rationale for triple receptor engagement in metabolic research centers on complementary pathway activation. GCGR signaling in hepatocyte and brown adipocyte models has been associated with enhanced energy expenditure markers, including upregulation of UCP1 and FGF21 expression. GLP-1R activation in β-cell models contributes to glucose-dependent insulin secretion, while GIPR signaling in adipocyte cultures influences lipid handling and adipokine secretion. In vitro studies combining these pathways have demonstrated metabolic gene expression profiles distinct from single- or dual-agonist treatments.\u003c\/p\u003e\n\u003cp\u003eResearch applications include comparative pharmacology studies with selective and dual agonists to delineate individual receptor contributions to observed metabolic effects. In hypothalamic neuronal models, triple receptor activation has been investigated for effects on anorexigenic and orexigenic neuropeptide expression. Hepatic steatosis cell models have utilized retatrutide to study multi-receptor-mediated effects on lipid droplet accumulation and lipotoxicity markers.\u003c\/p\u003e\n\u003cp\u003eTrimcore provides retatrutide as a lyophilized powder at ≥98% purity by HPLC with mass spectrometry identity confirmation, available in 4 mg and 12 mg research quantities. A comprehensive Certificate of Analysis accompanies each lot. Reconstitution in bacteriostatic water is recommended. Store lyophilized material at -20°C, protected from light. Reconstituted solutions at 2–8°C for up to 30 days. Handle under aseptic conditions with standard peptide protocols.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eFor research and laboratory use only. Not for human consumption.\u003c\/em\u003e\u003c\/p\u003e","brand":"Trimcore Peptide Solution","offers":[{"title":"Default Title","offer_id":52728332484897,"sku":null,"price":300.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0981\/7122\/4353\/files\/D8410AD1-19AA-4DAE-9448-E031DD927A3E.png?v=1779223579","url":"https:\/\/trimcorepeptide.com\/products\/r-e-t-a-t-r-u-t-i-d-e-40mg","provider":"Trimcore Peptide Solution","version":"1.0","type":"link"}